Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.

Autor: Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Kasidi JR; Infectious Diseases Research Collaboration, Kampala, Uganda., Kadota JL; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda., Kunihira LT; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Opira B; Infectious Diseases Research Collaboration, Kampala, Uganda., Baik Y; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Patel D; Department of Surgery, University of California San Francisco, San Francisco, California, United States of America.; The Better Lab, University of California, San Francisco, San Francisco, California, United States of America., Sammann A; Department of Surgery, University of California San Francisco, San Francisco, California, United States of America.; The Better Lab, University of California, San Francisco, San Francisco, California, United States of America., Berger CA; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Aschmann HE; Department of Epidemiology and Biostatistics and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, United States of America., Nahid P; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America., Kamya MR; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Handley MA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America., Phillips PPJ; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America., Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda., Katamba A; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Cattamanchi A; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, California, United States of America., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Katahoire AR; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Oct 24; Vol. 4 (10), pp. e0003347. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.

Autor: Aschmann HE; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Kadota JL; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Namale C; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Kakeeto J; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda., Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Berger C; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA USA.; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA., Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA USA., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Kerkhoff AD; Center for Tuberculosis, University of California San Francisco, San Francisco, CA USA.; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Sep 14. Date of Electronic Publication: 2023 Sep 14.